Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
1.045
-0.010 (-0.95%)
At close: Jan 7, 2026, 4:00 PM EST
1.038
-0.007 (-0.70%)
After-hours: Jan 7, 2026, 4:21 PM EST
Jupiter Neurosciences Market Cap
Jupiter Neurosciences has a market cap or net worth of $35.98 million as of January 7, 2026. Its market cap has decreased by -90.26% in one year.
Market Cap
35.98M
Enterprise Value
35.78M
1-Year Change
-90.26%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since the IPO on December 3, 2024, Jupiter Neurosciences's market cap has decreased from $132.40M to $35.98M, a decrease of -72.83%. That is a compound annual growth rate of -69.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 36.32M | 3.43% |
| Dec 31, 2025 | 35.11M | -90.09% |
| Dec 31, 2024 | 354.21M | 167.54% |
| Dec 3, 2024 | 132.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 991.30B |
| Johnson & Johnson | 498.75B |
| AbbVie | 406.87B |
| UnitedHealth Group | 307.85B |
| AstraZeneca | 293.89B |
| Merck & Co. | 273.02B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |